Revance therapeutics, inc. (rvnc) investors who lost money have opportunity to lead securities fraud lawsuit

Los angeles , jan. 23, 2025 /prnewswire/ -- glancy prongay & murray llp announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against revance therapeutics, inc. ("revance" or the "company") (nasdaq: rvnc). if you suffered a loss on your revance investments, click here before march 4, 2025 (lead plaintiff deadline) to participate in the securities fraud lawsuit what is the lawsuit about?
RVNC Ratings Summary
RVNC Quant Ranking